Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The process of developing stable cell lines often starts with transfecting selected host cells, typically CHO or HEK 293 cells with desired plasmids.
The global Cell Line Development market size is expected to reach US$ 2542.3 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Cell Line Development in various end use industries. The expanding demands from the Bioproduction, Tissue Engineering & Regenerative Medicines, Toxicity Testing and Research, are propelling Cell Line Development market. Incubators, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Centrifuges segment is estimated at % CAGR for the next seven-year period.
There is an increase in demand for the cell line development market owing to the increasing demand for monoclonal antibodies, rising vaccine production and use of innovative technologie.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell Line Development, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell Line Development market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell Line Development market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell Line Development sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell Line Development covered in this report include Corning, GE Healthcare, Lonza, Sartorius, Selexis, Sigma-Aldrich, Thermo Fisher Scientific and Wuxi Apptec, etc.
The global Cell Line Development market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Cell Line Development market, by region:
Global Cell Line Development market, Segment by Type:
Global Cell Line Development market, by Application
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell Line Development companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Cell Line Development
1.1 Cell Line Development Market Overview
1.1.1 Cell Line Development Product Scope
1.1.2 Cell Line Development Market Status and Outlook
1.2 Global Cell Line Development Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell Line Development Market Size by Region (2018-2029)
1.4 Global Cell Line Development Historic Market Size by Region (2018-2023)
1.5 Global Cell Line Development Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell Line Development Market Size (2018-2029)
1.6.1 North America Cell Line Development Market Size (2018-2029)
1.6.2 Europe Cell Line Development Market Size (2018-2029)
1.6.3 Asia-Pacific Cell Line Development Market Size (2018-2029)
1.6.4 Latin America Cell Line Development Market Size (2018-2029)
1.6.5 Middle East & Africa Cell Line Development Market Size (2018-2029)
2 Cell Line Development Market by Type
2.1 Introduction
2.1.1 Incubators
2.1.2 Centrifuges
2.1.3 Bioreactors
2.1.4 Storage Equipment
2.1.5 Automated Systems
2.1.6 Microscopes
2.1.7 Filtration Systems
2.1.8 Others
2.2 Global Cell Line Development Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell Line Development Historic Market Size by Type (2018-2023)
2.2.2 Global Cell Line Development Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell Line Development Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell Line Development Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell Line Development Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell Line Development Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell Line Development Revenue Breakdown by Type (2018-2029)
3 Cell Line Development Market Overview by Application
3.1 Introduction
3.1.1 Bioproduction
3.1.2 Tissue Engineering & Regenerative Medicines
3.1.3 Toxicity Testing
3.1.4 Research
3.1.5 Drug Discovery
3.2 Global Cell Line Development Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell Line Development Historic Market Size by Application (2018-2023)
3.2.2 Global Cell Line Development Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell Line Development Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell Line Development Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell Line Development Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell Line Development Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell Line Development Revenue Breakdown by Application (2018-2029)
4 Cell Line Development Competition Analysis by Players
4.1 Global Cell Line Development Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Line Development as of 2022)
4.3 Date of Key Players Enter into Cell Line Development Market
4.4 Global Top Players Cell Line Development Headquarters and Area Served
4.5 Key Players Cell Line Development Product Solution and Service
4.6 Competitive Status
4.6.1 Cell Line Development Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Corning
5.1.1 Corning Profile
5.1.2 Corning Main Business
5.1.3 Corning Cell Line Development Products, Services and Solutions
5.1.4 Corning Cell Line Development Revenue (US$ Million) & (2018-2023)
5.1.5 Corning Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Cell Line Development Products, Services and Solutions
5.2.4 GE Healthcare Cell Line Development Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Lonza
5.3.1 Lonza Profile
5.3.2 Lonza Main Business
5.3.3 Lonza Cell Line Development Products, Services and Solutions
5.3.4 Lonza Cell Line Development Revenue (US$ Million) & (2018-2023)
5.3.5 Sartorius Recent Developments
5.4 Sartorius
5.4.1 Sartorius Profile
5.4.2 Sartorius Main Business
5.4.3 Sartorius Cell Line Development Products, Services and Solutions
5.4.4 Sartorius Cell Line Development Revenue (US$ Million) & (2018-2023)
5.4.5 Sartorius Recent Developments
5.5 Selexis
5.5.1 Selexis Profile
5.5.2 Selexis Main Business
5.5.3 Selexis Cell Line Development Products, Services and Solutions
5.5.4 Selexis Cell Line Development Revenue (US$ Million) & (2018-2023)
5.5.5 Selexis Recent Developments
5.6 Sigma-Aldrich
5.6.1 Sigma-Aldrich Profile
5.6.2 Sigma-Aldrich Main Business
5.6.3 Sigma-Aldrich Cell Line Development Products, Services and Solutions
5.6.4 Sigma-Aldrich Cell Line Development Revenue (US$ Million) & (2018-2023)
5.6.5 Sigma-Aldrich Recent Developments
5.7 Thermo Fisher Scientific
5.7.1 Thermo Fisher Scientific Profile
5.7.2 Thermo Fisher Scientific Main Business
5.7.3 Thermo Fisher Scientific Cell Line Development Products, Services and Solutions
5.7.4 Thermo Fisher Scientific Cell Line Development Revenue (US$ Million) & (2018-2023)
5.7.5 Thermo Fisher Scientific Recent Developments
5.8 Wuxi Apptec
5.8.1 Wuxi Apptec Profile
5.8.2 Wuxi Apptec Main Business
5.8.3 Wuxi Apptec Cell Line Development Products, Services and Solutions
5.8.4 Wuxi Apptec Cell Line Development Revenue (US$ Million) & (2018-2023)
5.8.5 Wuxi Apptec Recent Developments
6 North America
6.1 North America Cell Line Development Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cell Line Development Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell Line Development Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell Line Development Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell Line Development Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell Line Development Market Dynamics
11.1 Cell Line Development Industry Trends
11.2 Cell Line Development Market Drivers
11.3 Cell Line Development Market Challenges
11.4 Cell Line Development Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research